## Pathophysiology of Hyperpigmentation in Pityriasis Versicolor ### Understanding the Color Variants Pityriasis versicolor classically presents with **two color patterns**: | Pattern | Mechanism | Clinical Context | |---------|-----------|------------------| | **Hypopigmented (most common)** | Malassezia produces dicarboxylic acids (azelaic acid) → inhibits tyrosinase → reduced melanin synthesis | Fair skin, sun-exposed areas | | **Hyperpigmented** | Malassezia produces melanin-stimulating substances (MSH-like factors) → increased melanin synthesis | Darker skin types, less sun-exposed areas | **Key Point:** The **same organism (Malassezia furfur)** produces different pigmentary changes depending on: - **Skin phototype** (darker skin → hyperpigmentation; fair skin → hypopigmentation) - **Sun exposure** (exposed areas → hypopigmentation; covered areas → hyperpigmentation) - **Inflammatory response** of the individual ### Mechanism of Hyperpigmentation **High-Yield:** Malassezia furfur secretes **melanin-stimulating hormone (MSH)-like peptides** and other mediators that: 1. Stimulate melanocytes to increase melanin production 2. Enhance melanosome transfer to keratinocytes 3. Result in **clinically darker patches** overlying the infection site This is in contrast to the hypopigmented variant, where the organism's **dicarboxylic acids inhibit tyrosinase**, the rate-limiting enzyme in melanin synthesis. ### Clinical Significance **Clinical Pearl:** In a patient with darker skin phototype living in a humid, tropical climate (like Bangalore), the **hyperpigmented variant is more common** because: - The organism preferentially produces melanin-stimulating factors in these individuals - Covered body areas (trunk, shoulders) are more prone to hyperpigmentation - The baseline melanin production is already high **Mnemonic: DARK SKIN = DARK SPOTS** — In darker-skinned individuals, PV tends to present as hyperpigmented patches; in fair-skinned individuals, it presents as hypopigmented patches. ### Why Recurrence Occurs This patient's **recurrent infection despite topical therapy** is explained by: 1. **Malassezia is part of normal skin flora** — it cannot be eradicated permanently 2. **Predisposing factors persist** — oily skin, humid climate, genetic susceptibility 3. **Inadequate systemic therapy** — topical agents may not penetrate deeply into sebaceous glands where the organism resides **Tip:** For recurrent PV, consider **systemic antifungal therapy** (fluconazole 150 mg weekly × 2–4 weeks) or **maintenance therapy** with monthly topical or oral antifungals. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.